Global Secondary Progressive Multiple Sclerosis Drug Market Research Report 2016-2026

Table of Contents
1 Market Overview
1.1 Objectives of Research
1.1.1 Definition
Figure Secondary Progressive Multiple Sclerosis Drug Picture
1.1.2 Specifications
Table Product Specifications of Secondary Progressive Multiple Sclerosis Drug
1.2 Market Segment
1.2.1 by Type
Table Products Segment of Secondary Progressive Multiple Sclerosis Drug
Table Global Secondary Progressive Multiple Sclerosis Drug Market by Type, 2016-2026 (USD Million)
1.2.1.1 Inebilizumab
Table Inebilizumab Overview
1.2.1.2 GLX-1112
Table GLX-1112 Overview
1.2.1.3 DC-TAB
Table DC-TAB Overview
1.2.1.4 Etomoxir
Table Etomoxir Overview
1.2.1.5 IB-MS
Table IB-MS Overview
1.2.1.6 Others
Table Others Overview
1.2.2 by Application
Table Application Segment of Secondary Progressive Multiple Sclerosis Drug
Table Global Secondary Progressive Multiple Sclerosis Drug Market by Application, 2016-2026 (USD Million)
1.2.2.1 Hospital
Table Hospital Overview
1.2.2.2 Clinic
Table Clinic Overview
1.2.2.3 Others
Table Others Overview
1.2.3 by Regions
Table Global Secondary Progressive Multiple Sclerosis Drug Market by Region, 2016-2026 (USD Million)
2 Industry Chain
2.1 Industry Chain Structure
Figure Industry Chain Structure of Secondary Progressive Multiple Sclerosis Drug
2.2 Upstream
Table Cost of Secondary Progressive Multiple Sclerosis Drug
Figure Manufacturing Process of Secondary Progressive Multiple Sclerosis Drug
2.3 Market
2.3.1 SWOT
Figure SWOT of Secondary Progressive Multiple Sclerosis Drug
2.3.2 Dynamics
Table Market Dynamics
3 Environmental Analysis
3.1 Policy
Table Policy of Secondary Progressive Multiple Sclerosis Drug
3.2 Economic
Table GDP of Major Countries
3.3 Technology
Table Technology of Secondary Progressive Multiple Sclerosis Drug
3.4 Market Entry
Table Market Entry of Secondary Progressive Multiple Sclerosis Drug
4 Market Segmentation by Type
4.1 Market Size
4.1.1 Inebilizumab Market, 2016-2020
Figure Inebilizumab Market Size and Growth, 2016-2020 (USD Million)
Figure Inebilizumab Market Size and Growth, 2016-2020 (in Volume)
Table Inebilizumab CAGR by Revenue and Volume, 2016-2020
4.1.2 GLX-1112 Market, 2016-2020
Figure GLX-1112 Market Size and Growth, 2016-2020 (USD Million)
Figure GLX-1112 Market Size and Growth, 2016-2020 (in Volume)
Table GLX-1112 CAGR by Revenue and Volume, 2016-2020
4.1.3 DC-TAB Market, 2016-2020
Figure DC-TAB Market Size and Growth, 2016-2020 (USD Million)
Figure DC-TAB Market Size and Growth, 2016-2020 (in Volume)
Table DC-TAB CAGR by Revenue and Volume, 2016-2020
4.1.4 Etomoxir Market, 2016-2020
Figure Etomoxir Market Size and Growth, 2016-2020 (USD Million)
Figure Etomoxir Market Size and Growth, 2016-2020 (in Volume)
Table Etomoxir CAGR by Revenue and Volume, 2016-2020
4.1.5 IB-MS Market, 2016-2020
Figure IB-MS Market Size and Growth, 2016-2020 (USD Million)
Figure IB-MS Market Size and Growth, 2016-2020 (in Volume)
Table IB-MS CAGR by Revenue and Volume, 2016-2020
4.1.6 Others Market, 2016-2020
Figure Others Market Size and Growth, 2016-2020 (USD Million)
Figure Others Market Size and Growth, 2016-2020 (in Volume)
Table Others CAGR by Revenue and Volume, 2016-2020
4.2 Market Forecast
4.2.1 Inebilizumab Market Forecast, 2021-2026
Figure Inebilizumab Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure Inebilizumab Market Estimates and Forecasts, 2021-2026 (in Volume)
Table Inebilizumab CAGR by Revenue and Volume, 2016-2026
4.2.2 GLX-1112 Market Forecast, 2021-2026
Figure GLX-1112 Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure GLX-1112 Market Estimates and Forecasts, 2021-2026 (in Volume)
Table GLX-1112 CAGR by Revenue and Volume, 2016-2026
4.2.3 DC-TAB Market Forecast, 2021-2026
Figure DC-TAB Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure DC-TAB Market Estimates and Forecasts, 2021-2026 (in Volume)
Table DC-TAB CAGR by Revenue and Volume, 2016-2026
4.2.4 Etomoxir Market Forecast, 2021-2026
Figure Etomoxir Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure Etomoxir Market Estimates and Forecasts, 2021-2026 (in Volume)
Table Etomoxir CAGR by Revenue and Volume, 2016-2026
4.2.5 IB-MS Market Forecast, 2021-2026
Figure IB-MS Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure IB-MS Market Estimates and Forecasts, 2021-2026 (in Volume)
Table IB-MS CAGR by Revenue and Volume, 2016-2026
4.2.6 Others Market Forecast, 2021-2026
Figure Others Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure Others Market Estimates and Forecasts, 2021-2026 (in Volume)
Table Others CAGR by Revenue and Volume, 2016-2026
5 Market Segmentation by Application
5.1 Market Size
5.1.1 Hospital Market, 2016-2020
Figure Hospital Market Size and Growth, 2016-2020 (USD Million)
Figure Market Size and Growth, 2016-2020 (in Volume)
Table Hospital CAGR by Revenue and Volume, 2016-2020
5.1.2 Clinic Market, 2016-2020
Figure Clinic Market Size and Growth, 2016-2020 (USD Million)
Figure Market Size and Growth, 2016-2020 (in Volume)
Table Clinic CAGR by Revenue and Volume, 2016-2020
5.1.3 Others Market, 2016-2020
Figure Others Market Size and Growth, 2016-2020 (USD Million)
Figure Market Size and Growth, 2016-2020 (in Volume)
Table Others CAGR by Revenue and Volume, 2016-2020
5.2 Market Forecast
5.2.1 Hospital Market Forecast, 2021-2026
Figure Hospital Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure Hospital Market Estimates and Forecasts, 2021-2026 (in Volume)
Table Hospital CAGR by Revenue and Volume, 2021-2026
5.2.2 Clinic Market Forecast, 2021-2026
Figure Clinic Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure Clinic Market Estimates and Forecasts, 2021-2026 (in Volume)
Table Clinic CAGR by Revenue and Volume, 2021-2026
5.2.3 Others Market Forecast, 2021-2026
Figure Others Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure Others Market Estimates and Forecasts, 2021-2026 (in Volume)
Table Others CAGR by Revenue and Volume, 2021-2026
6 Market Segmentation by Region
6.1 Market Size
6.1.1 Asia-Pacific
6.1.1.1 Asia-Pacific Market, 2016-2020
Figure Asia-Pacific Market Size and Growth, 2016-2020 (USD Million)
Figure Asia-Pacific Market Size and Growth, 2016-2020 (in Volume)
Table Asia-Pacific CAGR by Revenue and Volume, 2016-2020
6.1.1.2 Asia-Pacific Market by Type
Figure Asia-Pacific Market Size by Type
Figure Asia-Pacific Market Share by Type
6.1.1.3 Asia-Pacific Market by Application
Figure Asia-Pacific Market Size by Application
Figure Asia-Pacific Market Share by Application
6.1.2 North America
6.1.2.1 North America Market, 2016-2020
Figure North America Market Size and Growth, 2016-2020 (USD Million)
Figure North America Market Size and Growth, 2016-2020 (in Volume)
Table North America CAGR by Revenue and Volume, 2016-2020
6.1.2.2 North America Market by Type
Figure North America Market Size by Type
Figure North America Market Share by Type
6.1.2.3 North America Market by Application
Figure North America Market Size by Application
Figure North America Market Share by Application
6.1.3 Europe
6.1.3.1 Europe Market, 2016-2020
Figure Europe Market Size and Growth, 2016-2020 (USD Million)
Figure Europe Market Size and Growth, 2016-2020 (in Volume)
Table Europe CAGR by Revenue and Volume, 2016-2020
6.1.3.2 Europe Market by Type
Figure Europe Market Size by Type
Figure Europe Market Share by Type
6.1.3.3 Europe Market by Application
Figure Europe Market Size by Application
Figure Europe Market Share by Application
6.1.4 South America
6.1.4.1 South America Market, 2016-2020
Figure South America Market Size and Growth, 2016-2020 (USD Million)
Figure South America Market Size and Growth, 2016-2020 (in Volume)
Table South America CAGR by Revenue and Volume, 2016-2020
6.1.4.2 South America Market by Type
Figure South America Market Size by Type
Figure South America Market Share by Type
6.1.4.3 South America Market by Application
Figure South America Market Size by Application
Figure South America Market Share by Application
6.1.5 Middle East & Africa
6.1.5.1 Middle East & Africa Market, 2016-2020
Figure Middle East & Africa Market Size and Growth, 2016-2020 (USD Million)
Figure Middle East & Africa Market Size and Growth, 2016-2020 (in Volume)
Table Middle East & Africa CAGR by Revenue and Volume, 2016-2020
6.1.5.2 Middle East & Africa Market by Type
Figure Middle East & Africa Market Size by Type
Figure Middle East & Africa Market Share by Type
6.1.5.3 Middle East & Africa Market by Application
Figure Middle East & Africa Market Size by Application
Figure Middle East & Africa Market Share by Application
6.2 Market Forecast
6.2.1 Asia-Pacific Market Forecast, 2021-2026
Figure Asia-Pacific Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure Asia-Pacific Market Estimates and Forecasts, 2021-2026 (in Volume)
Table Asia-Pacific CAGR by Revenue and Volume, 2021-2026
6.2.2 North America Market Forecast, 2021-2026
Figure North America Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure North America Market Estimates and Forecasts, 2021-2026 (in Volume)
Table North America CAGR by Revenue and Volume, 2021-2026
6.2.3 Europe Market Forecast, 2021-2026
Figure Europe Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure Europe Market Estimates and Forecasts, 2021-2026 (in Volume)
Table Europe CAGR by Revenue and Volume, 2021-2026
6.2.4 South America Market Forecast, 2021-2026
Figure South America Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure South America Market Estimates and Forecasts, 2021-2026 (in Volume)
Table South America CAGR by Revenue and Volume, 2021-2026
6.2.5 Middle East & Africa Market Forecast, 2021-2026
Figure Middle East & Africa Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure Middle East & Africa Market Estimates and Forecasts, 2021-2026 (in Volume)
Table Middle East & Africa CAGR by Revenue and Volume, 2021-2026
7 Market Competitive
7.1 Global Market by Vendors
Table Global Secondary Progressive Multiple Sclerosis Drug Market by Vendors, 2016-2020 (in Volume)
Table Global Secondary Progressive Multiple Sclerosis Drug Market Share by Vendors, 2016-2020 (USD Million)
Table Global Secondary Progressive Multiple Sclerosis Drug Market Share by Vendors, 2016-2020 (in Volume)
7.2 Market Concentration
Figure Secondary Progressive Multiple Sclerosis Drug Market Concentration by Region
7.3 Price & Factors
Table Price Factors List
7.4 Marketing Channel
Figure Marketing Channels Overview
8 Major Vendors
8.1 AB Science SA
Table AB Science SA Profile List
Table Microecological Modulator Operating Data of AB Science SA (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.2 Actelion Ltd
Table Actelion Ltd Profile List
Table Microecological Modulator Operating Data of Actelion Ltd (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.3 Biogen, Inc.
Table Biogen, Inc. Profile List
Table Microecological Modulator Operating Data of Biogen, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.4 F. Hoffmann-La Roche Ltd.
Table F. Hoffmann-La Roche Ltd. Profile List
Table Microecological Modulator Operating Data of F. Hoffmann-La Roche Ltd. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.5 Genzyme Corporation
Table Genzyme Corporation Profile List
Table Microecological Modulator Operating Data of Genzyme Corporation (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.6 Glialogix, Inc.
Table Glialogix, Inc. Profile List
Table Microecological Modulator Operating Data of Glialogix, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.7 Immune Response BioPharma, Inc.
Table Immune Response BioPharma, Inc. Profile List
Table Microecological Modulator Operating Data of Immune Response BioPharma, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.8 Innate Immunotherapeutics Ltd
Table Innate Immunotherapeutics Ltd Profile List
Table Microecological Modulator Operating Data of Innate Immunotherapeutics Ltd (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.9 Kyorin Pharmaceutical Co., Ltd.
Table Kyorin Pharmaceutical Co., Ltd. Profile List
Table Microecological Modulator Operating Data of Kyorin Pharmaceutical Co., Ltd. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.10 Mallinckrodt Plc
Table Mallinckrodt Plc Profile List
Table Microecological Modulator Operating Data of Mallinckrodt Plc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.11 MedDay SA
Table MedDay SA Profile List
Table Microecological Modulator Operating Data of MedDay SA (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.12 MedImmune, LLC
Table MedImmune, LLC Profile List
Table Microecological Modulator Operating Data of MedImmune, LLC (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.13 Merck KGaA
Table Merck KGaA Profile List
Table Microecological Modulator Operating Data of Merck KGaA (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.14 Meta-IQ ApS
Table Meta-IQ ApS Profile List
Table Microecological Modulator Operating Data of Meta-IQ ApS (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.15 Novartis AG
Table Novartis AG Profile List
Table Microecological Modulator Operating Data of Novartis AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.16 Opexa Therapeutics, Inc.
Table Opexa Therapeutics, Inc. Profile List
Table Microecological Modulator Operating Data of Opexa Therapeutics, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.17 Xenetic Biosciences (UK) Limited
Table Xenetic Biosciences (UK) Limited Profile List
Table Microecological Modulator Operating Data of Xenetic Biosciences (UK) Limited (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9 Conclusion